Administration of radioactive iodine therapy within 1 year after total thyroidectomy does not affect vocal function

Journal of Nuclear Medicine

Volumn 56, Issue 10, 2015, Pages 1480-1486

  Ryu, Chang Hwan ^a   Ryu, Junsun ^a   Ryu, Youn Mi ^a   Lee, You Jin ^a   Lee, Eun Kyung ^a   Kim, Seok Ki ^a   Kim, Tae Sung ^a   Kim, Tae Hyun ^a   Lee, Chang Yoon ^a   Park, Seog Yun ^a   Chung, Ki Wook ^b   Jung, Yuh S ^a  

^a National Cancer Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Radioactive iodine; Thyroid cancer; Total thyroidectomy; Voice

Indexed keywords

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRADE ROUGHNESS BREATHINESS ASTHENIA AND STRAIN SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PITCH; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; RADIOACTIVE IODINE THERAPY; SPEECH AND LANGUAGE; SYMPTOM; THYROID CANCER; THYROIDECTOMY; VOCAL FUNCTION; VOCAL QUALITY; VOICE; VOICE DISORDER; VOICE HANDICAP INDEX; VOICE ROUGHNESS; VOICE STRAIN; AGED; COHORT ANALYSIS; COMPLICATION; LARYNGOSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RADIATION RESPONSE; THYROID NEOPLASMS; VERY ELDERLY; VOCAL CORD; VOICE DISORDERS;

RADIOACTIVE IODINE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; IODINE RADIOISOTOPES; LARYNGOSCOPY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; THYROID NEOPLASMS; THYROIDECTOMY; VOCAL CORDS; VOICE; VOICE DISORDERS;

EID: 84943177361     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.115.161463     Document Type: Article

References (35)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Kim WB. A closer look at papillary thyroid carcinoma. Endocrinol Metab (Seoul). 2015;30:1-6.
3. Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714-720.
4. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418-428.
5. Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc. 1995;106:151-168.
6. 131I ablation for papillary and follicular thyroid carcinoma. Thyroid. 1997;7:265-271.
7. Taylor T, Specker B, Robbins J, et al. Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma. Ann Intern Med. 1998;129:622-627.
8. Sawka AM, Brierley JD, Tsang RW, et al. An updated systematic review and commentary examining the effectiveness of radioactive iodine remnant ablation in well-differentiated thyroid cancer. Endocrinol Metab Clin North Am. 2008;37: 457-480.
9. Van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer. Thyroid. 2009; 19: 1381-1391.
10. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid. J Am Med Assoc. 1946;132: 838-847.
11. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
12. Evidence-based cancer guidelines, oncology drug compendium, and oncology continuing medical education. National Comprehensive Cancer Network website. http://www.nccn.org/. Accessed August 12, 2015.
13. Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine. Int J Radiat Oncol Biol Phys. 1996;35:535-540.
14. Mandel SJ, Mandel L. Radioactive iodine and the salivary glands. Thyroid. 2003;13:265-271.
15. Solans R, Bosch J-A, Galofré P, et al. Salivary and lacrimal gland dysfunction (Sicca syndrome) after radioiodine therapy. J Nucl Med. 2001;42:738-743.
16. Jeong SY, Kim HW, Lee S-W, Ahn B-C, Lee J. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre-and postablation scintigraphies and their relation to xerostomia symptoms. Thyroid. 2013;23:609-616.
17. Caglar M, Tuncel M, Alpar R. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment. Clin Nucl Med. 2002;27:767-771.
18. Raza H, Khan AU, Hameed A, Khan A. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun. 2006;27:495-499.
19. Roy N, Merrill RM, Gray SD, Smith EM. Voice disorders in the general population: prevalence, risk factors, and occupational impact. Laryngoscope. 2005;115: 1988-1995.
20. Mirza N, Ruiz C, Baum ED, Staab JP. The prevalence of major psychiatric pathologies in patients with voice disorders. Ear Nose Throat J. 2003;82:808-810, 812, 814.
21. Roh J-L, Kim A-Y, Cho MJ. Xerostomia following radiotherapy of the head and neck affects vocal function. J Clin Oncol. 2005;23:3016-3023.
22. Roh J-L, Kim HS, Kim A-Y. The effect of acute xerostomia on vocal function. Arch Otolaryngol Head Neck Surg. 2006;132:542-546.
23. Ryu J, Ryu YM, Jung Y-S, et al. Extent of thyroidectomy affects vocal and throat functions: a prospective observational study of lobectomy versus total thyroid-ectomy. Surgery. 2013;154:611-620.
24. Vicente DA, Solomon NP, Avital I, et al. Voice outcomes after total thy-roidectomy, partial thyroidectomy, or non-neck surgery using a prospective multifactorial assessment. J Am Coll Surg. 2014;219:152-163.
25. Sinagra DL, Montesinos MR, Tacchi VA, et al. Voice changes after thyroidectomy without recurrent laryngeal nerve injury. J Am Coll Surg. 2004;199:556-560.
26. Stojadinovic A, Shaha AR, Orlikoff RF, et al. Prospective functional voice assessment in patients undergoing thyroid surgery. Ann Surg. 2002;236:823-832.
27. Hong KH, Kim YK. Phonatory characteristics of patients undergoing thyroidec-tomy without laryngeal nerve injury. Otolaryngol Head Neck Surg. 1997;117: 399-404.
28. Aluffi P, Policarpo M, Cherovac C, Olina M, Dosdegani R, Pia F. Post-thyroidectomy superior laryngeal nerve injury. Eur Arch Otorhinolaryngol. 2001;258:451-454.
29. Ritter FN. The effect of hypothyroidism on the larynx of the rat: an explanation for hoarseness associated with hypothyroidism in the human. Ann Otol Rhinol Laryngol. 1964;73:404-416.
30. Isolan-Cury RW, Monte O, Cury AN, et al. Acute effects of radioiodine therapy on the voice and larynx of Basedow-Graves patients. Braz J Otorhinolaryngol. 2008;74:224-229.
31. Schlumberger M, Catargi B, Borget I, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. N Engl J Med. 2012;366:1663-1673.
32. Mallick U, Harmer C, Yap B, et al. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer. N Engl J Med. 2012;366:1674-1685.
33. Leydon C, Sivasankar M, Falciglia DL, Atkins C, Fisher KV. Vocal fold surface hydration: a review. J Voice. 2009;23:658-665.
34. Fisher KV, Ligon J, Sobecks JL, Roxe DM. Phonatory effects of body fluid removal. J Speech Lang Hear Res. 2001;44:354-367.
35. Jiang J, Verdolini K, Aquino B, Ng J, Hanson D. Effects of dehydration on phonation in excised canine larynges. Ann Otol Rhinol Laryngol. 2000;109: 568-575.